Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBI
851
DELISTED
Hanesbrands
HBI
| $15.9M | 0.01% |
863,825
+58,918
| +7% | +$1.14M |
|
852
Berkshire Hathaway Class A
BRK.A
$1.07T
| $15.7M | 0.01% |
49
-2
| -4% | -$619K |
|
|
TWO
853
Two Harbors Investment
TWO
$1.27B
| $15.6M | 0.01% |
261,537
-6,528
| -2% | -$407K |
|
|
BFX
854
DELISTED
BowFlex Inc.
BFX
| $15.5M | 0.01% |
1,114,324
-10,155
| -0.9% | -$146K |
|
855
Viking Therapeutics
VKTX
$4.05B
| $15.5M | 0.01% |
891,442
-1,168,844
| -57% | -$13.9M |
|
856
PBF Energy
PBF
$7.43B
| $15.5M | 0.01% |
309,600
+92,800
| +43% | +$4.41M |
|
857
Nuveen Taxable Municipal Income Fund
NBB
$447M
| $15.3M | 0.01% |
763,061
+10,000
| +1% | +$205K |
|
858
Sabre
SABR
$704M
| $15.2M | 0.01% |
582,467
-26,703
| -4% | -$685K |
|
859
Vail Resorts
MTN
$5.28B
| $15.1M | 0.01% |
54,997
+16,249
| +42% | +$4.68M |
|
860
Crinetics Pharmaceuticals
CRNX
$8.87B
| $15M | 0.01% |
+524,744
| New | +$15.6M |
|
861
Gentex
GNTX
$4.88B
| $14.8M | 0.01% |
691,808
+85,670
| +14% | +$1.98M |
|
|
JWN
862
DELISTED
Nordstrom
JWN
| $14.8M | 0.01% |
248,043
+187,609
| +310% | +$10.7M |
|
863
Unum
UNM
$13.8B
| $14.8M | 0.01% |
378,926
-867,370
| -70% | -$32.4M |
|
864
HDFC Bank
HDB
$119B
| $14.7M | 0.01% |
626,592
-64,076
| -9% | -$1.63M |
|
865
Pediatrix Medical
MD
$2.15B
| $14.6M | 0.01% |
313,859
-2,967
| -0.9% | -$136K |
|
866
HEICO Corp
HEI
$49.9B
| $14.5M | 0.01% |
156,525
+6,236
| +4% | +$513K |
|
|
BDN
867
Brandywine Realty Trust
BDN
$533M
| $14.5M | 0.01% |
920,835
+111,993
| +14% | +$1.85M |
|
868
Canadian Pacific Kansas City
CP
$81.1B
| $14.4M | 0.01% |
339,210
+67,085
| +25% | +$2.68M |
|
869
Canadian Imperial Bank of Commerce
CM
$108B
| $14.3M | 0.01% |
305,294
-25,632
| -8% | -$1.18M |
|
|
AZPN
870
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $14.3M | 0.01% |
+125,200
| New | +$14.3M |
|
871
Devon Energy
DVN
$49.8B
| $14.2M | 0.01% |
355,253
+211,880
| +148% | +$9.02M |
|
872
American Financial Group
AFG
$12B
| $14.2M | 0.01% |
127,671
-22,600
| -15% | -$2.51M |
|
|
WPX
873
DELISTED
WPX Energy, Inc.
WPX
| $14.1M | 0.01% |
700,100
+301,200
| +76% | +$5.58M |
|
|
GRFS
874
Grifois
GRFS
$5.27B
| $14.1M | 0.01% |
658,202
-233,347
| -26% | -$4.93M |
|
875
Charter Communications
CHTR
$15.7B
| $14M | 0.01% |
42,808
-65,076
| -60% | -$19.9M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.